Market Access News | pharmaphorum

News

Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.

News

The UK government's threat to withdraw from negotiations on rebates paid by industry on NHS medicines has been followed by the collapse of talks.

News

Ionis gets FDA nod for its HAE attack prophylactic treatment Dawnzera, offering less frequent dosing than its rivals.

News

Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.

News

Johnson & Johnson has filled in some of the detail in its $55 billion investment in US facilities announced earlier this year.

News

A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green light for NHS use.